Stearoyl coenzyme A lithium
Stearoyl coenzyme A lithium structure
|
Common Name | Stearoyl coenzyme A lithium | ||
|---|---|---|---|---|
| CAS Number | 193402-48-1 | Molecular Weight | 1034 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C39H66Li4N7O17P3S | Melting Point | N/A | |
| MSDS | USA | Flash Point | N/A | |
Use of Stearoyl coenzyme A lithiumStearoyl coenzyme A (Stearoyl-CoA) lithium is an active compound that can be used as a substrate for the determination of stearoyl-Coenzyme desaturase in microsomes[1]. |
| Name | Stearoyl coenzyme A lithium salt |
|---|---|
| Synonym | More Synonyms |
| Description | Stearoyl coenzyme A (Stearoyl-CoA) lithium is an active compound that can be used as a substrate for the determination of stearoyl-Coenzyme desaturase in microsomes[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C39H66Li4N7O17P3S |
|---|---|
| Molecular Weight | 1034 |
| Exact Mass | 1057.408936 |
| Water Solubility | Soluble in water. |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
|
Stearoyl-CoA desaturase: a vital checkpoint in the development and progression of obesity.
Endocr. Metab. Immune Disord. Drug Targets 11 , 217-231, (2011) Stearoyl-CoA desaturase 1 (SCD-1) is the rate-limiting enzyme that catalyses the conversion of saturated to monounsaturated fatty acids. Increased SCD-1 expression and activity has been implicated in ... |
|
|
Stearoyl-CoA desaturase-1: a novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer.
Carcinogenesis 31 , 1509-1515, (2010) As part of a shift toward macromolecule production to support continuous cell proliferation, cancer cells coordinate the activation of lipid biosynthesis and the signaling networks that stimulate this... |
|
|
Elevated stearoyl-CoA desaturase in brains of patients with Alzheimer's disease.
PLoS ONE 6 , e24777, (2011) The molecular bases of Alzheimer's disease (AD) remain unclear. We used a lipidomic approach to identify lipid abnormalities in the brains of subjects with AD (N = 37) compared to age-matched controls... |
| Adenosine, 5'-O-[hydroxy[[hydroxy[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-[[2-[(1-oxooctadecyl)thio]ethyl]amino]propyl]amino]butoxy]phosphinyl]oxy]phosphinyl]-, 3'-(dihydrogen phosphate), lithium salt (1:4) |
| n-Octadecanoyl Coenzyme A |